Cornercap Investment Counsel Inc Harmony Biosciences Holdings, Inc. Transaction History
Cornercap Investment Counsel Inc
- $329 Million
- Q3 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 8,790 shares of HRMY stock, worth $299,387. This represents 0.11% of its overall portfolio holdings.
Number of Shares
8,790
Previous 17,366
49.38%
Holding current value
$299,387
Previous $523,000
32.89%
% of portfolio
0.11%
Previous 0.09%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.1MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$382 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$199 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$118 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$88.8 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$65.7 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.02B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...